DexCom stockholders approve equity plan share increases and elect directors

DEXCOM INC

Stockholders approved 3.4M new shares under Amended & Restated 2015 Equity Incentive Plan.
Stockholders approved 8M new shares under Amended & Restated 2015 Employee Stock Purchase Plan.
Board size reduced to 9 directors effective May 8, 2025.
All nine director nominees elected, including Kevin Sayer and Steven R. Altman.
Ratified Deloitte & Touche as independent auditor for fiscal year 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.